Edition:
United States

Entellus Medical Inc (ENTL.OQ)

ENTL.OQ on NASDAQ Stock Exchange Global Market

24.63USD
15 Dec 2017
Change (% chg)

$0.33 (+1.36%)
Prev Close
$24.30
Open
$24.29
Day's High
$24.75
Day's Low
$24.24
Volume
223,921
Avg. Vol
62,030
52-wk High
$24.75
52-wk Low
$11.48

Latest Key Developments (Source: Significant Developments)

Discovery Group I LLC Says Dissolves Stake In Entellus Medical As Of December 7
Friday, 8 Dec 2017 04:14pm EST 

Dec 8 (Reuters) - Entellus Medical Inc ::DISCOVERY GROUP I LLC SAYS DISSOLVES STAKE IN ENTELLUS MEDICAL INC AS OF DECEMBER 7 - SEC FILING.DISCOVERY GROUP I LLC SAYS HAD PREVIOUSLY REPORTED A STAKE OF 7.5 PERCENT IN ENTELLUS MEDICAL INC AS OF NOVEMBER 14.  Full Article

Entellus Medical Says Deal May Require Co To Pay Stryker A Termination Fee Of $20.5 Mln
Thursday, 7 Dec 2017 08:50am EST 

Dec 7 (Reuters) - Entellus Medical Inc ::ENTELLUS MEDICAL SAYS DEAL PROVIDES CO MAY BE REQUIRED TO PAY STRYKER TERMINATION FEE OF $20.5 MILLION UNDER CERTAIN CIRCUMSTANCES - SEC FILING.  Full Article

Stryker to buy Entellus Medical for $24.00/share in cash
Thursday, 7 Dec 2017 08:15am EST 

Dec 7 (Reuters) - Entellus Medical Inc ::ENTELLUS MEDICAL ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR A PURCHASE PRICE OF $24.00 PER SHARE IN CASH.DEAL FOR EQUITY VALUE OF ABOUT $662 MILLION.‍ENTELLUS BOARD OF DIRECTORS UNANIMOUSLY APPROVED ENTERING INTO AGREEMENT​.  Full Article

Entellus Medical reports Q3 loss per share $0.13
Wednesday, 1 Nov 2017 04:05pm EDT 

Nov 1 (Reuters) - Entellus Medical Inc :Entellus Medical Inc announces third quarter 2017 financial results.Q3 loss per share $0.13.Q3 revenue $23.3 million versus I/B/E/S view $23.3 million.Q3 earnings per share view $-0.49 -- Thomson Reuters I/B/E/S.Entellus Medical Inc - ‍Entellus recorded a special income tax benefit related to Spirox acquisition, totaling $14.9 million during q3 of 2017​.Entellus Medical Inc - ‍expects fy revenue, inclusive of anticipated Spirox revenue from July 13 through year end, to be in a range of $92.0 million to $94.0 million​.  Full Article

Entellus Medical says files for resale of up to aggregate of 10.23 mln of common stock by the selling stockholders
Monday, 25 Sep 2017 04:57pm EDT 

Sept 25 (Reuters) - Entellus Medical Inc :Entellus Medical Inc files for resale of up to aggregate of 10.23 million of common stock by the selling stockholders - sec filing‍​.  Full Article

Entellus Medical Q2 loss per share $0.37
Thursday, 3 Aug 2017 04:03pm EDT 

Aug 3 (Reuters) - Entellus Medical Inc ::Entellus Medical announces second quarter 2017 financial results.Q2 loss per share $0.37.Q2 revenue $22.1 million versus I/B/E/S view $21.5 million.Q2 earnings per share view $-0.34 -- Thomson Reuters I/B/E/S.Sees Q3 2017 revenue up 27 to 33 percent.Entellus Medical Inc - expects fy17 revenue, inclusive of anticipated Spirox revenue from July 13 to year end, to be in range of $91.5 million to $94.5 million.  Full Article

KKR Fund Holdings LP reports 5.5 pct stake in Entellus Medical
Friday, 21 Jul 2017 05:05pm EDT 

July 21 (Reuters) - Entellus Medical Inc :KKR Fund Holdings LP reports 5.5 percent stake in Entellus Medical Inc as of July 13 - SEC filing.  Full Article

Entellus Medical borrowes additional $26.5 mln in term loans
Friday, 14 Jul 2017 06:43am EDT 

July 14 (Reuters) - Entellus Medical Inc -:Entellus Medical- ‍on July 13, related to closing of merger with spirox, co borrowed additional $26.5 million in term loans to fund initial cash consideration.Entellus Medical Inc- term loans under loan agreement mature and amounts borrowed under agreement become due and payable on march 1, 2022 - sec filing‍​.Entellus Medical Inc - additional borrowing brings total term loan borrowings under loan agreement to $40.0 million in three tranches.Entellus Medical Inc - under loan agreement, co may borrow up to $10.0 million under revolving line of credit, subject to a borrowing base requirement.  Full Article

Entellus Medical says ‍either party may terminate merger agreement if merger with Spirox is not consummated on or before Dec 31 - SEC Filing​
Friday, 7 Jul 2017 08:49am EDT 

July 7 (Reuters) - Entellus Medical Inc :Entellus Medical - ‍either party may terminate merger agreement if merger with Spirox is not consummated on or before December 31, 2017 - SEC Filing​.Entellus Medical - Agreed to increase size of board from seven to nine, elect James Momtazee and Douglas Rohlen as directors of Entellus​.  Full Article

Entellus Medical to acquire Spirox Inc
Friday, 7 Jul 2017 08:03am EDT 

July 7 (Reuters) - Entellus Medical Inc ::Entellus to acquire Spirox for $25 million in cash and 3.4 million shares of entellus common stock.Says raising FY 2017 revenue expectations to be $91.5 million to $94.5 million.Sees Q2 revenue $21.9 million to $22.1 million.Says deal includes ‍additional contingent payments over four years based on revenue growth.Q2 revenue view $21.3 million -- Thomson Reuters I/B/E/S.FY2017 revenue view $87.0 million -- Thomson Reuters I/B/E/S.Says to add Duke Rohlen, CEO of Spirox, Jim Momtazee, director of Spirox, head of KKR's Health Care Industry Team - Americas, to co's board.  Full Article

BRIEF-Discovery Group I LLC Says Dissolves Stake In Entellus Medical As Of December 7

* DISCOVERY GROUP I LLC SAYS DISSOLVES STAKE IN ENTELLUS MEDICAL INC AS OF DECEMBER 7 - SEC FILING